ArticleEuropean journal of medical research2025
Accurate forecasting in acute ischemic stroke: innovative nomogram models for early neurological deterioration and 90-day prognosis outcomes following intravenous thrombolysis.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- A new nomogram for predicting the risk of ischemic early neurological deterioration after intravenous thrombolysis in acute ischemic stroke: a multicenter retrospective study.BMC neurology · 2026Article
- Development and validation of a DWI-based intra- and peri-infarction radiomics model for predicting neurological deterioration in acute ischemic stroke.Frontiers in neurology · 2026Article
- Unraveling family resilience patterns in ICU first-episode stroke: a latent profile analysis.Frontiers in psychology · 2026Article
- Development of a nomogram prediction model for thrombolytic outcomes in acute ischemic stroke.BMC neurology · 2025Article
- Hemoglobin-albumin-lymphocyte-platelet score and early neurological deterioration in acute ischemic stroke: a single-center retrospective cohort study.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeThis study aimed to develop novel nomogram models capable of predicting early neurological deterioration (END) and 90-day prognosis outcomes in acute ischemic stroke (AIS) patients treated with IV thrombolysis.
methodsA retrospective derivation cohort comprising 298 AIS patients was enrolled from January 2021 to March 2024. A separate validation cohort of 94 patients was retrospectively enrolled between April 2024 and December 2024. END was defined as a sustained NIHSS increase of ≥ 2 points within 24 h, and poor prognosis outcome a mRS score of 3-6 at 90 days. Multivariate logistic regression analysis was employed to construct nomogram models for the prediction of outcomes.
resultsIn the derivation cohort, 23.83% patients with END experienced a poor 90-day outcome, as compared to 12.42% of those from NO-END group. Independent risk factors for END included a lower initial NIHSS score, a delayed DNT, a reduced ASPECTS score, and incomplete Willis Artery. END patients were found to be at a significantly increased risk of poor 90-day prognosis (odds ratio 0.163, p < 0.001). In addition, elevated initial NIHSS and glucose levels, the presence of nonlacunar infarction, and history of hypertension were predictive of poor prognosis. Two separate nomogram models, developed based on the previously identified risk factors to predict the occurrence of END and a poor 90-day prognosis, demonstrated AUC values of 0.740 (95% CI 0.686-0.789) and 0.859 (95% CI 0.814-0.896). These models also exhibited good discriminatory capacity in the validation cohort, with corresponding AUC values of 0.716 (95% CI 0.541-0.892) and 0.795 (95% CI 0.689-0.900).
conclusionThis study has successfully constructed reliable nomogram models for forecasting END and poor 90-day outcomes in AIS patients treated with IV thrombolysis; thereby, facilitating personalized prediction of adverse outcomes and adjustment of treatment strategy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.